Literature DB >> 12682439

Proteases and lung injury.

Theo J Moraes1, Chung-Wai Chow, Gregory P Downey.   

Abstract

OBJECTIVE: Acute respiratory distress syndrome (ARDS) represents an inflammatory process that is initiated by diverse systemic and/or pulmonary insults, resulting in a clinical syndrome of severe respiratory distress and refractory hypoxemia. Neutrophils and their cytotoxic products, including oxidants and proteases, such as elastase, have been implicated as playing a key role in the pathophysiology of ARDS. This article reviews some of the physiologic actions of proteases, specifically elastase, the evidence for neutrophil elastase involvement in ARDS, and the potential therapeutic use of neutrophil elastase inhibitors in lung injury. DATA SOURCE: A review of published literature (original articles and reviews) in English from 1965 to 2002.
CONCLUSION: Although the data support a key role for neutrophil elastase in the pathogenesis of ARDS, further study is needed to fully define the actions of neutrophil elastase, and how these actions affect host functions, before we can exploit this knowledge for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682439     DOI: 10.1097/01.CCM.0000057842.90746.1E

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  54 in total

1.  Dual function inhibitors of relevance to chronic obstructive pulmonary disease.

Authors:  Dengfeng Dou; Guijia He; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem Lett       Date:  2010-12-10       Impact factor: 2.823

2.  Impact of host proteases on reovirus infection in the respiratory tract.

Authors:  Rachel M Nygaard; Joseph W Golden; Leslie A Schiff
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

Review 3.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Effects of structure on inhibitory activity in a series of mechanism-based inhibitors of human neutrophil elastase.

Authors:  Dengfeng Dou; Guijia He; Rongze Kuang; Qingfong Fu; Radhika Venkataraman; William C Groutas
Journal:  Bioorg Med Chem       Date:  2010-08-05       Impact factor: 3.641

5.  Involvement of Kallikrein-Kinin System on Cardiopulmonary Alterations and Inflammatory Response Induced by Purified Aah I Toxin from Scorpion Venom.

Authors:  Wafa Medjadba; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 6.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

7.  Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.

Authors:  Haitao Liu; Emma M Lessieur; Aicha Saadane; Sarah I Lindstrom; Patricia R Taylor; Timothy S Kern
Journal:  Diabetologia       Date:  2019-10-14       Impact factor: 10.122

8.  The clinical practice guideline for the management of ARDS in Japan.

Authors:  Satoru Hashimoto; Masamitsu Sanui; Moritoki Egi; Shinichiro Ohshimo; Junji Shiotsuka; Ryutaro Seo; Ryoma Tanaka; Yu Tanaka; Yasuhiro Norisue; Yoshiro Hayashi; Eishu Nango
Journal:  J Intensive Care       Date:  2017-07-25

9.  Ventilator-induced endothelial activation and inflammation in the lung and distal organs.

Authors:  Maria A Hegeman; Marije P Hennus; Cobi J Heijnen; Patricia Ac Specht; Burkhard Lachmann; Nicolaas Jg Jansen; Adrianus J van Vught; Pieter M Cobelens
Journal:  Crit Care       Date:  2009-11-16       Impact factor: 9.097

10.  Expression and activity of N-myristoyltransferase in lung inflammation of cattle and its role in neutrophil apoptosis.

Authors:  Anuraag Shrivastav; Sarabjeet S Suri; Ryan Mohr; Kyathanahalli S Janardhan; Rajendra K Sharma; Baljit Singh
Journal:  Vet Res       Date:  2009-10-02       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.